301267 华厦眼科
已收盘 10-13 15:00:00
资讯
新帖
简况
华厦眼科:10月12日高管苏庆灿增持股份合计10万股
证券之星 · 10-13 21:01
华厦眼科:10月12日高管苏庆灿增持股份合计10万股
华厦眼科(301267)披露关于变更董事会秘书的公告,10月12日股价下跌0.26%
证券之星 · 10-12 17:53
华厦眼科(301267)披露关于变更董事会秘书的公告,10月12日股价下跌0.26%
股市必读:华厦眼科新发布《第四届董事会第四次会议决议公告》
证券之星 · 10-12 03:43
股市必读:华厦眼科新发布《第四届董事会第四次会议决议公告》
华厦眼科:9月28日高管苏庆灿增持股份合计2.7万股
证券之星 · 09-29
华厦眼科:9月28日高管苏庆灿增持股份合计2.7万股
股市必读:华厦眼科(301267)9月24日披露最新机构调研信息
证券之星 · 09-28
股市必读:华厦眼科(301267)9月24日披露最新机构调研信息
【机构调研记录】安信基金调研华厦眼科
证券之星 · 09-25
【机构调研记录】安信基金调研华厦眼科
顶级专家余克明加盟 华厦眼科加码屈光“人才战”
中金财经 · 09-23
顶级专家余克明加盟 华厦眼科加码屈光“人才战”
华厦眼科:9月17日高管苏庆灿增持股份合计4.41万股
证券之星 · 09-18
华厦眼科:9月17日高管苏庆灿增持股份合计4.41万股
华厦眼科:9月15日高管苏庆灿增持股份合计10.1万股
证券之星 · 09-16
华厦眼科:9月15日高管苏庆灿增持股份合计10.1万股
华厦眼科:公司实际控制人、董事长增持公司股份系基于对公司未来发展的信心及对公司长期投资价值的认可
证券之星 · 09-16
华厦眼科:公司实际控制人、董事长增持公司股份系基于对公司未来发展的信心及对公司长期投资价值的认可
华厦眼科:北京华厦民众和天津华厦是公司在津京冀地区的重要战略布局
证券之星 · 09-16
华厦眼科:北京华厦民众和天津华厦是公司在津京冀地区的重要战略布局
研报掘金丨东海证券:维持华厦眼科“买入”评级,屈光项目增长良好,业绩整体平稳
格隆汇 · 09-15
研报掘金丨东海证券:维持华厦眼科“买入”评级,屈光项目增长良好,业绩整体平稳
华厦眼科:截至目前公司未收到进一步通知
证券之星 · 09-15
华厦眼科:截至目前公司未收到进一步通知
华厦眼科:9月11日高管苏庆灿增持股份合计13.5万股
证券之星 · 09-14
华厦眼科:9月11日高管苏庆灿增持股份合计13.5万股
东海证券:给予华厦眼科买入评级
证券之星 · 09-14
东海证券:给予华厦眼科买入评级
华厦眼科:9月9日高管苏庆灿增持股份合计6万股
证券之星 · 09-10
华厦眼科:9月9日高管苏庆灿增持股份合计6万股
华厦眼科:9月7日高管苏庆灿增持股份合计7.4万股
证券之星 · 09-08
华厦眼科:9月7日高管苏庆灿增持股份合计7.4万股
华厦眼科中报增速放缓,二季度多项指标转弱,两大募投项目进度不足12%
证券之星 · 09-08
华厦眼科中报增速放缓,二季度多项指标转弱,两大募投项目进度不足12%
华厦眼科:9月2日高管苏庆灿增持股份合计10000股
证券之星 · 09-03
华厦眼科:9月2日高管苏庆灿增持股份合计10000股
9月1日增减持汇总:恒工精密等12股拟减持,华厦眼科拟增持(表)
新浪证券 · 09-01
9月1日增减持汇总:恒工精密等12股拟减持,华厦眼科拟增持(表)
加载更多
公司概况
公司名称:
华厦眼科医院集团股份有限公司
所属行业:
卫生
上市日期:
2022-11-07
主营业务:
华厦眼科医院集团股份有限公司的主营业务是眼科医疗服务。公司的主要产品是白内障专科、屈光专科、眼底病专科、斜弱视与小儿眼科专科、眼表病专科、青光眼专科、眼眶与眼肿瘤专科、眼外伤专科、眼视光。公司下属医院厦门眼科中心是国家三级甲等专科医院、国家临床重点专科(眼科)建设单位,并设有博士后科研工作站和院士专家工作站。
发行价格:
50.88
{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":15,"timestamp":1791875037000,"preClose":15.12,"halted":0,"volume":4076123,"delay":0,"changeRate":-0.0079,"floatShares":648000000,"shares":840000000,"eps":0.5365,"marketStatus":"已收盘","change":-0.12,"latestTime":"10-13 15:00:00","open":15.11,"high":15.11,"low":14.78,"amount":60937000,"amplitude":0.0218,"askPrice":15.01,"askSize":23,"bidPrice":15,"bidSize":76,"shortable":0,"etf":0,"ttmEps":0.5365,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":5,"adr":0,"adjPreClose":15.12,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":16.63,"lowLimit":13.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.34,"roa":"--","peRate":27.958993,"roe":"5.41%","epsLYR":0.53,"committee":0.049798,"marketValue":12600000000,"turnoverRate":0.0063,"status":1,"floatMarketCap":9727000000},"requestUrl":"/m/hq/s/301267","defaultTab":"news","newsList":[{"id":"2675352495","title":"华厦眼科:10月12日高管苏庆灿增持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675352495","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675352495?lang=zh_cn&edition=full","pubTime":"2026-10-13 21:01","pubTimestamp":1791896485,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月13日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年10月12日公司高管,董事苏庆灿共增持公司股份10.0万股,占公司总股本为0.0119%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出236.27万,融资余额减少;融券净流入1.33万,融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300037642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876132","title":"华厦眼科(301267)披露关于变更董事会秘书的公告,10月12日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876132","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876132?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:53","pubTimestamp":1791798783,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘,华厦眼科报收于15.12元,较前一交易日下跌0.26%,最新总市值为127.01亿元。该股当日开盘15.16元,最高15.23元,最低15.01元,成交额达3188.73万元,换手率为0.33%。近日,华厦眼科医院集团股份有限公司发布《关于变更董事会秘书的公告》。公告显示,公司于2026年10月9日召开第四届董事会第四次会议,审议通过聘任杨未来女士为公司董事会秘书,任期至第四届董事会任期届满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200024417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674846935","title":"股市必读:华厦眼科新发布《第四届董事会第四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674846935","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674846935?lang=zh_cn&edition=full","pubTime":"2026-10-12 03:43","pubTimestamp":1791747791,"startTime":"0","endTime":"0","summary":"公司公告汇总第四届董事会第四次会议决议公告华厦眼科医院集团股份有限公司于2026年10月9日召开第四届董事会第四次会议,审议通过《关于聘任董事会秘书的议案》;聘任杨未来女士为公司董事会秘书,任期至第四届董事会任期届满;会议由李晓峰主持,7名董事全部出席,表决结果为同意7票,反对0票,弃权0票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671121245","title":"华厦眼科:9月28日高管苏庆灿增持股份合计2.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671121245","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671121245?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:01","pubTimestamp":1790686884,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月29日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月28日公司高管,董事苏庆灿共增持公司股份2.7万股,占公司总股本为0.0032%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出344.36万,融资余额减少;融券净流出1.69万,融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900037848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670484409","title":"股市必读:华厦眼科(301267)9月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2670484409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670484409?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:59","pubTimestamp":1790531949,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,华厦眼科报收于14.91元,下跌1.32%,换手率0.46%,成交量2.96万手,成交额4441.5万元。机构调研要点:截至2026年6月30日,公司已在全国19个省及直辖市运营64家眼科专科医院和55家视光中心。机构调研要点:公司2025年中期及年度分红合计2.16亿元,现金分红比例达49.12%;已披露《未来三年股东分红回报规划》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670416007","title":"【机构调研记录】安信基金调研华厦眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2670416007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670416007?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:01","pubTimestamp":1790294500,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及9月24日披露的机构调研信息,安信基金近期对1家上市公司进行了调研,相关名单如下:1)华厦眼科 调研纪要:目前,公司屈光手术高端术式占比超过50%,今年屈光业务整体呈量价齐升的良好趋势。截至2026年6月30日,公司已开设64家眼科专科医院和55家视光中心,将持续推进全国布局。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500004813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669617083","title":"顶级专家余克明加盟 华厦眼科加码屈光“人才战”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669617083","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669617083?lang=zh_cn&edition=full","pubTime":"2026-09-23 13:42","pubTimestamp":1790142122,"startTime":"0","endTime":"0","summary":"中国网财经9月23日讯 近日,原中山眼科中心近视眼激光治疗科主任余克明教授正式加盟华厦眼科医院集团,担任华厦眼科医院集团大湾区名誉院长、深圳南山华厦眼科医院首席专家、广州华厦维尔视眼科首席专家,同时受聘为华厦眼科医院集团学术委员会眼屈光学组主任委员。公开信息显示,余克明已受聘为华厦眼科医院集团学术委员会眼屈光学组主任委员,并入选“中国眼科医师明日之星计划”屈光手术技术规范化培训组指导专家。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/23/20260923973015.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/23/20260923973015.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260923/32378733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668792663","title":"华厦眼科:9月17日高管苏庆灿增持股份合计4.41万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668792663","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668792663?lang=zh_cn&edition=full","pubTime":"2026-09-18 21:01","pubTimestamp":1789736499,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月18日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月17日公司高管,董事苏庆灿共增持公司股份4.41万股,占公司总股本为0.0053%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入12.77万,融资余额增加;融券净流入1.05万,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800035348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667798544","title":"华厦眼科:9月15日高管苏庆灿增持股份合计10.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667798544","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667798544?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:01","pubTimestamp":1789563709,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月16日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月15日公司高管,董事苏庆灿共增持公司股份10.1万股,占公司总股本为0.012%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出62.89万,融资余额减少;融券净流出2.71万,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667743656","title":"华厦眼科:公司实际控制人、董事长增持公司股份系基于对公司未来发展的信心及对公司长期投资价值的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2667743656","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667743656?lang=zh_cn&edition=full","pubTime":"2026-09-16 11:48","pubTimestamp":1789530488,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科09月15日在投资者关系平台上答复投资者关心的问题。市场期待获奖者在投资者关系管理和信息披露质量上树立标杆。截至最新披露,公司机构持仓已降至1.3%左右,流动性处于市场后10%水平,并因此触发指数调出及被动资金外流。公司实际控制人、董事长增持公司股份系基于对公司未来发展的信心及对公司长期投资价值的认可。再次感谢您对华厦眼科的支持!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600015366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667712066","title":"华厦眼科:北京华厦民众和天津华厦是公司在津京冀地区的重要战略布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2667712066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667712066?lang=zh_cn&edition=full","pubTime":"2026-09-16 11:33","pubTimestamp":1789529597,"startTime":"0","endTime":"0","summary":"证券之星消息,华厦眼科09月15日在投资者关系平台上答复投资者关心的问题。投资者提问:2026年9月10日,在中华医学会第三十次眼科学术大会启幕首日,华厦眼科与博士伦举行战略合作签约仪式。北京华厦民众和天津华厦是公司在津京冀地区的重要战略布局,其中北京也是公司规划建设区域眼科中心的六个城市之一。再次感谢您对华厦眼科的支持!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600014412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667061216","title":"研报掘金丨东海证券:维持华厦眼科“买入”评级,屈光项目增长良好,业绩整体平稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2667061216","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667061216?lang=zh_cn&edition=full","pubTime":"2026-09-15 15:39","pubTimestamp":1789457940,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0236","301267","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667161397","title":"华厦眼科:截至目前公司未收到进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2667161397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667161397?lang=zh_cn&edition=full","pubTime":"2026-09-15 11:37","pubTimestamp":1789443466,"startTime":"0","endTime":"0","summary":"根据华厦眼科在2025年10月10日回复投资者的公开信息,针对“苏庆灿目前仍处于被公安机关监视居住的状态”的提问,公司明确表示:“截至目前,公司暂未收到进一步通知。”请问截至目前,公司是否已收到办案机关关于解除其实控人监视居住的正式书面通知?请予以明确回复,谢谢华厦眼科回复:尊敬的投资者您好,感谢您对华厦眼科的关注。再次感谢您对华厦眼科的支持!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500015767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693136","title":"华厦眼科:9月11日高管苏庆灿增持股份合计13.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667693136?lang=zh_cn&edition=full","pubTime":"2026-09-14 21:01","pubTimestamp":1789390900,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月14日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月11日公司高管,董事苏庆灿共增持公司股份13.5万股,占公司总股本为0.0161%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出254.97万,融资余额减少;融券净流出3.18万,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400031240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657060","title":"东海证券:给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667657060?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:27","pubTimestamp":1789381636,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对华厦眼科进行研究并发布了研究报告《公司简评报告:屈光项目增长良好,业绩整体平稳》,给予华厦眼科买入评级。 期间费用控制良好,科研实力持续提升。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家;过去90天内机构目标均价为23.87。本文数据来源于东海证券股份有限公司,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400027157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559653","title":"华厦眼科:9月9日高管苏庆灿增持股份合计6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559653","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666559653?lang=zh_cn&edition=full","pubTime":"2026-09-10 21:01","pubTimestamp":1789045291,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月10日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月9日公司高管,董事苏庆灿共增持公司股份6.0万股,占公司总股本为0.0071%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出539.47万,融资余额减少;融券净流出1.38万,融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000040437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731743","title":"华厦眼科:9月7日高管苏庆灿增持股份合计7.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731743","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665731743?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:02","pubTimestamp":1788872522,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月8日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月7日公司高管,董事苏庆灿共增持公司股份7.4万股,占公司总股本为0.0088%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出481.49万,融资余额减少;融券净流出1.14万,融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800034788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340537","title":"华厦眼科中报增速放缓,二季度多项指标转弱,两大募投项目进度不足12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665340537?lang=zh_cn&edition=full","pubTime":"2026-09-08 14:47","pubTimestamp":1788850069,"startTime":"0","endTime":"0","summary":"财报显示,今年上半年,华厦眼科实现营收21.85亿元,同比增长2.17%;归属净利润2.92亿元,同比增长3.55%。从单季度表现来看,业绩回落的趋势更加清晰:华厦眼科第一季度营收、归属净利润、扣非后净利润分别同比增长5.22%、14.69%、10.09%,但进入第二季度,三项指标骤然转弱,分别同比下降1.02%、9.06%和22.47%,环比亦呈大幅下滑。减持公告发布后,8月28日华厦眼科股价应声下跌5.03%,8月31日继续下跌1.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026090800018914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872248","title":"华厦眼科:9月2日高管苏庆灿增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872248","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664872248?lang=zh_cn&edition=full","pubTime":"2026-09-03 21:01","pubTimestamp":1788440507,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月3日市场公开信息、上市公司公告及交易所披露数据整理,华厦眼科最新董监高及相关人员股份变动情况:2026年9月2日公司高管,董事苏庆灿共增持公司股份1.0万股,占公司总股本为0.0012%。华厦眼科近半年内的董监高及核心技术人员增减持详情如下:华厦眼科的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入1848.61万,融资余额增加;融券净流入9.46万,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300040131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664185212","title":"9月1日增减持汇总:恒工精密等12股拟减持,华厦眼科拟增持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664185212","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664185212?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:15","pubTimestamp":1788272100,"startTime":"0","endTime":"0","summary":"9月1日盘后,据不完全统计,包括怡亚通、恒工精密、维宏股份、九州一轨、中曼石油、上海洗霸、拱东医疗、今创集团、东北制药、金域医学、永臻股份、富春染织在内的12家A股上市公司披露拟减持情况,华厦眼科披露拟增持情况。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-01/doc-iniqitrs1600522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0259","301261","BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791916581709,"stockEarnings":[{"period":"1week","weight":-0.0106},{"period":"1month","weight":0.0225},{"period":"3month","weight":-0.0741},{"period":"6month","weight":-0.1191},{"period":"1year","weight":-0.2183},{"period":"ytd","weight":-0.1563}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"20129人(较上一季度减少5.38%)","perCapita":"32214股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":" 华厦眼科医院集团股份有限公司的主营业务是眼科医疗服务。公司的主要产品是白内障专科、屈光专科、眼底病专科、斜弱视与小儿眼科专科、眼表病专科、青光眼专科、眼眶与眼肿瘤专科、眼外伤专科、眼视光。公司下属医院厦门眼科中心是国家三级甲等专科医院、国家临床重点专科(眼科)建设单位,并设有博士后科研工作站和院士专家工作站。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}